跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BOTOX - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BOTOX
Authorized
STANDARD
BOTOX
Abbvie Corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f7f070afaf26ef17
Company
Abbvie Corporation
Type
Standard
Approval Details
Approval Id
f7f070afaf26ef17
Drug Approval Canada Name
BOTOX
Product Name
BOTOX
Status
Marketed
Status Date
2023-06-20
Original Market Date
2023-06-20
Din
02531577
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intramuscular
Schedule
Schedule D , Prescription
Ahfs
12:20.20.24
Atc Original
M03AX01 BOTULINUM TOXIN
Atc Name
m 03 ax 01
Aig Number
0151557003
Company Name
Abbvie Corporation
Company Address
8401 Trans-Canada Highway, Saint-Laurent, Quebec, Canada, H4S 1Z1
Company Detail Path
/organization/abbvie-corporation
Company Information
Pharmaceutical Company Name
Abbvie Corporation
Country Name
Canada
Province Name
Quebec
City Name
saint-laurent,quebec,country_ca
Address
8401 rte Transcanadienne
Active Ingredients
ONABOTULINUMTOXINA
50 UNIT / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f7f070afaf26ef17
Type
Standard
Back to Health Canada Approvals